Andrew Cheng - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Andrew Cheng

This paper is made freely available by the publisher.

2023 Stephen A. Harrison

ORCID

, Peter J. Ruane, Bradley Freilich, Guy Neff, Rashmee Patil, Cynthia Behling, Chen Hu, Reshma Shringarpure

ORCID

, Brittany de Temple, Erica Fong, Erik J. Tillman

ORCID

, Timothy Rolph

ORCID

, Andrew Cheng

ORCID

, Kitty Yale

A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis

Download from doi.org

This paper is made freely available by the publisher.

2021 Stephen A. Harrison, Peter J. Ruane, Bradley L. Freilich, Guy Neff, Rashmee Patil, Cynthia A. Behling, Chen Hu, Erica Fong, Brittany de Temple, Erik J. Tillman

ORCID

, Timothy P. Rolph, Andrew Cheng

ORCID

ORCID

Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

2017 Joel Gallant, Adriano Lazzarin, Anthony Mills, Chloe Orkin, Daniel Podzamczer, Pablo Tebas, Pierre-Marie Girard, Indira Brar, Eric S. Daar, David Wohl, Jürgen Rockstroh, Xuelian Wei, Joseph Custodio, Kirsten White, Hal Martin and 2 other authors

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Paul E. Sax, Anton Pozniak, M. Luisa Montes, Ellen Koenig, Edwin DeJesus, Hans-Jürgen Stellbrink, Andrea Antinori, Kimberly Workowski, Jihad Slim, Jacques Reynes, Will Garner, Joseph Custodio, Kirsten White, Devi SenGupta, Andrew Cheng

ORCID

and 1 other authors

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

2015 Paul E. Sax, David Wohl, Michael T. Yin, Frank Post, Edwin DeJesus, Michael Saag, Anton Pozniak, Melanie Thompson, Daniel Podzamczer, Jean Michel Molina, Shinichi Oka

ORCID

, Ellen Koenig, Benoit Trottier, Jaime Andrade-Villanueva, Gordon Crofoot and 9 other authors

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Upload

Missing publications? Search for publications with a matching author name.